<PAGE> 1
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form S-1 of our
reports dated March 3, 2000, except as to the fourth paragraph of Note 9, which
is as of October 5, 2000, and the stock split described in Note 14, which is as
of November 10, 2000, relating to the financial statements and financial
statement schedule of Cellomics, Inc., which appear in such Registration
Statement. We also consent to the references to us under the headings "Experts"
and "Selected Financial Data" in such Registration Statement.
PricewaterhouseCoopers LLP
Pittsburgh, Pennsylvania
November 16, 2000
